chr2-166288466-G-A
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.
The NM_001365536.1(SCN9A):c.1285C>T(p.Arg429Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000248 in 1,609,914 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R429H) has been classified as Likely benign.
Frequency
Consequence
NM_001365536.1 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| SCN9A | NM_001365536.1 | c.1285C>T | p.Arg429Cys | missense_variant | Exon 10 of 27 | ENST00000642356.2 | NP_001352465.1 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| SCN9A | ENST00000642356.2 | c.1285C>T | p.Arg429Cys | missense_variant | Exon 10 of 27 | NM_001365536.1 | ENSP00000495601.1 | |||
| SCN9A | ENST00000303354.11 | c.1285C>T | p.Arg429Cys | missense_variant | Exon 10 of 27 | 5 | ENSP00000304748.7 | |||
| SCN9A | ENST00000409672.5 | c.1285C>T | p.Arg429Cys | missense_variant | Exon 10 of 27 | 5 | ENSP00000386306.1 | |||
| SCN9A | ENST00000645907.1 | c.1285C>T | p.Arg429Cys | missense_variant | Exon 10 of 27 | ENSP00000495983.1 | ||||
| SCN9A | ENST00000454569.6 | c.1285C>T | p.Arg429Cys | missense_variant | Exon 10 of 15 | 1 | ENSP00000413212.2 | |||
| SCN9A | ENST00000452182.2 | c.*149C>T | downstream_gene_variant | 1 | ENSP00000393141.2 | 
Frequencies
GnomAD3 genomes  0.0000198  AC: 3AN: 151844Hom.:  0  Cov.: 31 show subpopulations 
GnomAD2 exomes  AF:  0.00000806  AC: 2AN: 248254 AF XY:  0.00   show subpopulations 
GnomAD4 exome  AF:  0.0000254  AC: 37AN: 1457952Hom.:  0  Cov.: 33 AF XY:  0.0000248  AC XY: 18AN XY: 725236 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000197  AC: 3AN: 151962Hom.:  0  Cov.: 31 AF XY:  0.0000404  AC XY: 3AN XY: 74270 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Channelopathy-associated congenital insensitivity to pain, autosomal recessive    Uncertain:2 
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
- -
Primary erythromelalgia    Uncertain:1Benign:1 
- -
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Inborn genetic diseases    Uncertain:1 
The p.R429C variant (also known as c.1285C>T), located in coding exon 9 of the SCN9A gene, results from a C to T substitution at nucleotide position 1285. The arginine at codon 429 is replaced by cysteine, an amino acid with highly dissimilar properties. This nucleotide position is well conserved in available vertebrate species. This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Febrile seizures, familial, 1    Uncertain:1 
- -
Generalized epilepsy with febrile seizures plus, type 7;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A    Uncertain:1 
This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 429 of the SCN9A protein (p.Arg429Cys). This variant is present in population databases (rs763256222, gnomAD 0.01%). This missense change has been observed in individual(s) with generalized epilepsy with febrile seizures (PMID: 31394368). ClinVar contains an entry for this variant (Variation ID: 548618). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SCN9A protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Generalized epilepsy with febrile seizures plus, type 7    Uncertain:1 
- -
Paroxysmal extreme pain disorder    Benign:1 
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at